Share on StockTwits

Cardinal Health (NYSE:CAH) has received a consensus recommendation of “Buy” from the twenty analysts that are currently covering the company, StockRatingsNetwork.com reports. Two investment analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $76.53.

Shares of Cardinal Health (NYSE:CAH) opened at 68.65 on Tuesday. Cardinal Health has a 1-year low of $43.45 and a 1-year high of $74.40. The stock has a 50-day moving average of $70.38 and a 200-day moving average of $65.8. The company has a market cap of $23.539 billion and a P/E ratio of 63.04.

Cardinal Health (NYSE:CAH) last announced its earnings results on Friday, January 31st. The company reported $0.79 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.84 by $0.05. The company had revenue of $22.20 billion for the quarter, compared to the consensus estimate of $20.74 billion. On average, analysts predict that Cardinal Health will post $3.84 earnings per share for the current fiscal year.

A number of research firms have recently commented on CAH. Analysts at Bank of America reiterated a “buy” rating on shares of Cardinal Health in a research note on Thursday, April 3rd. They now have a $76.00 price target on the stock, up previously from $75.00. Separately, analysts at Cowen and Company raised their price target on shares of Cardinal Health from $83.00 to $85.00 in a research note on Monday, March 24th. Finally, analysts at Ned Davis Research upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating in a research note on Monday, March 10th.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.